VanEck has recently expanded its TruSector ETF lineup with the introduction of two new funds: the VanEck Financials TruSector ETF (TRUF) and the VanEck Healthcare TruSector ETF (TRUH). This strategic move aims to provide investors with enhanced, focused exposure to mega-cap leaders within these critical sectors, bypassing the typical diversification limitations encountered by conventional sector-specific exchange-traded funds. The innovative TruSector methodology seeks to deliver a more accurate representation of market sectors, minimize tracking deviations, and reduce unintentional stock biases, all while adhering to regulatory compliance standards.

VanEck Launches Specialized TruSector ETFs on April 6, 2026

In a significant development for the investment community, on April 6, 2026, VanEck officially rolled out the VanEck Financials TruSector ETF (TRUF) and the VanEck Healthcare TruSector ETF (TRUH). These new offerings join an established suite of TruSector ETFs, including those for Consumer Discretionary (TRUD), Technology (TRUT), and Communication Services (TRUC), further solidifying VanEck's commitment to providing targeted investment vehicles. The core philosophy behind these funds revolves around delivering comprehensive market-cap sector exposure that closely mirrors the actual composition of these sectors in the broader market landscape. Both TRUF and TRUH are structured with a highly competitive expense ratio of just 0.10%, making them an attractive option for investors seeking precise sector allocations.

Key holdings within TRUF, the Financials TruSector ETF, include industry giants such as Berkshire Hathaway Inc, JPMorgan Chase & Co, and Visa Inc, collectively constituting nearly 31% of the portfolio. Similarly, TRUH, the Healthcare TruSector ETF, allocates approximately 32% of its assets to leading pharmaceutical and healthcare companies like Eli Lilly & Co, Johnson & Johnson, and Abbvie Inc. This concentrated approach allows for meaningful exposure to dominant players, a characteristic often diluted in broader sector ETFs due to diversification rules. These new ETFs are meticulously designed to maintain compliance with diversification limits, ensure lower tracking error compared to their traditional counterparts, and offer a cost-effective solution for investors aiming for nuanced sector investment strategies.

This initiative by VanEck highlights a forward-thinking approach to investment management, prioritizing depth of exposure and market accuracy. For investors, these new TruSector ETFs represent a valuable tool for refining portfolio construction, enabling them to gain more direct and impactful access to the performance of leading companies within the financials and healthcare sectors. The competitive expense ratio further enhances their appeal, offering a compelling blend of focused investment and cost efficiency in today's dynamic market environment.